Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$10.17 - $18.96 $6.51 Million - $12.1 Million
-640,070 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$11.67 - $18.07 $214,704 - $332,451
-18,398 Reduced 2.79%
640,070 $7.59 Million
Q2 2021

Aug 12, 2021

SELL
$16.25 - $21.51 $1.95 Million - $2.58 Million
-120,000 Reduced 15.41%
658,468 $11.3 Million
Q3 2020

Nov 12, 2020

BUY
$17.83 - $29.12 $13.9 Million - $22.7 Million
778,468 New
778,468 $16.4 Million

Others Institutions Holding OYST

About Oyster Point Pharma, Inc.


  • Ticker OYST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,831,500
  • Description
  • Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...
More about OYST
Track This Portfolio

Track Vida Ventures Advisors, LLC Portfolio

Follow Vida Ventures Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vida Ventures Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vida Ventures Advisors, LLC with notifications on news.